ABCB1 and breast carcinoma: In addition, treatment with berberine downregulates the expression of ABC transporters, including ABCB1 and ABCC1 (also known as multidrug resistance protein 1 (MRP1)), thereby improving anti-growth effects of doxorubicin on breast cancer in vivo [32].